Tue, October 29, 2019
Mon, October 28, 2019
Fri, October 25, 2019
Thu, October 24, 2019
Wed, October 23, 2019
Tue, October 22, 2019
Mon, October 21, 2019
Fri, October 18, 2019
Thu, October 17, 2019
Wed, October 16, 2019

Matthew Harrison Maintained (BIIB) at Sell with Increased Target to $262 on, Oct 23rd, 2019

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-increased-target-to-262-on-oct-23rd-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Sell with Increased Target from $212 to $262 on, Oct 23rd, 2019.

Matthew has made no other calls on BIIB in the last 4 months.



There is 1 other peer that has a rating on BIIB. Out of the 1 peers that are also analyzing BIIB, all agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $250 on, Friday, June 28th, 2019